Sleep, Cognition, and Memory
Wu 2018 (meta-analysis of cohorts) reports both short and long sleep associated with higher risk of cognitive disorders, with the lowest risk at 7 to 8 hours; Liang 2018 reports a pooled risk ratio per additional hour of 0.99, with 7 hours tending to carry the least risk; and cross-sectional studies report cognitive performance peaking at about 7 hours (Tai 2022; Richards 2017).
- Loud snoring with witnessed gasping/choking or breathing pauses plus daytime sleepiness (possible obstructive sleep apnea), refer to a clinician
- Difficulty falling or staying asleep at least 3 nights/week for 3+ months with daytime impairment (possible chronic insomnia disorder), refer to a clinician
- Excessive daytime sleepiness despite adequate time in bed, or falling asleep involuntarily during activities, refer to a clinician
What the evidence says
The sources on this entry are meta-analyses of cohort studies, cohort studies and cross-sectional studies of sleep duration and cognitive outcomes: cognitive disorders and dementia, cognitive performance and brain structure. Wu 2018 (dose-response meta-analysis, 9 cohorts, 22,187 participants) reports both short (RR 1.34) and long (RR 1.21) sleep associated with higher risk of cognitive disorders, with an approximately U-shaped dose-response and the lowest risk at 7-8 hours a day. Xu 2019 (meta-analysis, 51 cohort studies) reports insufficient (under 4 hours) or excessive (over 10 hours) sleep associated with higher risk of cognitive disorders, and concludes that sleep management might serve as a promising target for dementia prevention. Wang 2024 (meta-analysis of longitudinal studies, 35 records) reports insomnia, sleep-disordered breathing and both very short and long sleep associated with higher Alzheimer's disease risk, with self-reported sleep problems associated but objective measures not, and calls for validation with device-based assessment and causal confirmation. Against these, Liang 2018 (dose-response meta-analysis, 9 studies, 62,937 individuals) reports a pooled risk ratio per 1-hour increase of 0.99, with 7 hours tending to carry the least risk of mild cognitive impairment, dementia or cognitive decline. On performance and brain structure, Tai 2022 (cross-sectional) reports 7 hours of sleep associated with the highest cognitive performance, decreasing for each hour above or below, and 6-8 hours with greater grey matter volume. Richards 2017 (cross-sectional) reports performance peaking at 7 hours, with decrements for longer sleep comparable or greater in the youngest age groups than the oldest. Li 2022 (cohort) reports a nonlinear association with about 7 hours optimal and both insufficient and excessive sleep associated with cognitive decline at follow-up. Fjell 2023 (cross-sectional and longitudinal) reports no longitudinal association between sleep duration and brain atrophy, a cross-sectional inverse U-shape with 6.5 hours linked to the thickest cortex, and no causal effect in Mendelian randomisation, concluding that habitual short sleep does not cause brain atrophy. This entry reports associations; it does not assess or diagnose any cognitive disorder.
- Do not claim to diagnose, treat, or cure insomnia, sleep apnea, or any sleep disorder
- Do not promise guaranteed, instant, or permanent improvements in sleep
- Do not present these general hygiene techniques as clinical therapy (e.g., CBT-I) or a substitute for medical care
- Agreement
- Direction recorded for 0 of 8 sources; not yet recorded for the rest.
- The claim's outcome
- Outcome not yet recorded
- Certainty
- No source states a certainty rating.
- How the sources were read
- Some sources are based on abstracts, not full texts.
What each source measured and concluded (8)
- What it measured
- Occurrence of cognitive disorders (cognitive decline, dementia, Alzheimer's, cognitive impairment) by sleep duration
- How it was read
- based on the abstract, not the full text
- What the review says it includes
- Systematic review and dose-response meta-analysis
- Studies and participants, as stated
- N=9 cohort studies, 22,187 participants
- What it measured
- Risk of Alzheimer's disease by sleep characteristics
- How it was read
- based on the abstract, not the full text
- What the review says it includes
- Systematic review and meta-analysis of longitudinal studies
- Studies and participants, as stated
- N=35 records
- What it measured
- Mild cognitive impairment/dementia and cognitive decline risk by sleep duration
- How it was read
- based on the abstract, not the full text
- What the review says it includes
- Dose-response meta-analysis of observational studies
- Studies and participants, as stated
- N=9 studies; 62,937 individuals; 2718 MCI/dementia cases, 5596 cognitive decline cases
- What it measured
- Risk of all-cause cognitive disorders.
- How it measured it
- Multivariable-adjusted risk estimates and 95% CI (validated).
- How it was read
- read in full text
- What the review says it includes
- Meta-analysis of 51 cohort studies
- Studies and participants, as stated
- N=260,915 participants across 51 studies (specifically for insomnia-related analysis)
- Heterogeneity, as stated
- Limitations: High heterogeneity due to varying definitions and population characteristics, observational studies cannot establish causal relationships, lack of exploration of hypnotics and dementia subtypes, limited consideration of cardiovascular diseases as confounders.
- What it measured
- Nonlinear association between sleep duration, cognition, mental health, brain structure, and genetics
- How it was read
- screened only, not extracted
- What it measured
- Brain atrophy / brain structure (cortical thickness, volumes)
- How it was read
- screened only, not extracted
- What it measured
- Cognitive performance and brain structure (grey matter volume)
- How it was read
- screened only, not extracted
- What it measured
- Cognitive performance (processing speed, working memory, visuospatial memory, arithmetic)
- How it was read
- screened only, not extracted
Every source below is shown with its study design and links to the original study. This is the audit trail.
“Abstract only” means the review read that paper’s abstract, not its full text; “screened only” means it was included at re-screening and not extracted. Both stay in the trail with their DOI, because how a source was read is part of the audit.